Ulnar nerve transposition yielded low reoperation rates in throwing athletes
Click Here to Manage Email Alerts
NEW YORK — Throwing athletes who underwent ulnar nerve transposition were able to return to play with low reoperation rates, according to results presented at the American Shoulder and Elbow Surgeons Annual Meeting.
Steven B. Cohen, MD, and colleagues collected a questionnaire about return to play and re-injury from 23 throwing athletes who underwent isolated ulnar nerve transposition.
“Clinical outcomes included return to play, any type of ipsilateral elbow or shoulder injury and we looked at the [Kerlan-Jobe Orthopaedic Clinic] KJOC scores postoperatively,” Cohen said in his presentation here.
At an average follow-up of about 5 years, Cohen noted 16 patients completed the KJOC score and return-to-play questionnaire. Patients had an average KJOC score of 63 postoperatively, according to Cohen. He added 100% of patients returned to throwing.
“However, 13 of the 16 returned to formal overhead sports and the average time back was about 6 months,” Cohen said.
Of the 13 patients who returned to their formal overhead sports, Cohen noted 10 patients returned at the same level or higher.
“Regarding postoperative injuries to the shoulder and elbow, seven patients reported sustaining injury to the shoulder or elbow,” Cohen said. “One sustained [ulnar collateral ligament] UCL injury but did not require surgery. Three patients sustained a concomitant rotator cuff and labrum injury that did not require surgery. Three patients had isolated labral injuries, two of which required surgery for a labral debridement and superior labral repair.” – by Casey Tingle
Reference:
Hadley CJ, et al. Paper 23. Presented at: American Shoulder and Elbow Surgeons Annual Meeting; Oct. 17-19, 2019; New York.
Disclosure: Cohen reports he is a board or committee member for the American Orthopaedic Society for Sports Medicine and International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine; receives research support from Arthrex Inc. and Major League Baseball; is a paid consultant for ConMed Linvatec and Zimmer; receives publishing royalties, financial or material support from SLACK Incorporated; and receives IP royalties from and is a paid presenter or speaker for Zimmer.